Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials

被引：0
|
作者：
Amit Kumar Tripathi
Anup Kumar Ray
Sunil Kumar Mishra
机构：
[1] Banaras Hindu University,Molecular Biology Unit, Institute of Medical Science
[2] Galgotias University,Clinical Research Division, School of Basic and Applied Science
[3] Indian Institute of Technology (Banaras Hindu University,Department of Pharmaceutical Engineering and Technology
[4] I.T.S College of Pharmacy,Department of Pharmacognosy
来源：
Beni-Suef University Journal of Basic and Applied Sciences | / 11卷
关键词：
Anticancer; Piperine; Pharmacokinetics; Extractions; Clinical trials; COVID-19; Gut microbiota;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms
    Nirumand, Mina Cheraghi
    Hajialyani, Marziyeh
    Rahimi, Roja
    Farzaei, Mohammad Hosein
    Zingue, Stephane
    Nabavi, Seyed Mohammad
    Bishayee, Anupam
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (03)
  • [22] The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials
    Wetwittayakhlang, Panu
    Al Khoury, Alex
    Hahn, Gustavo Drugg
    Lakatos, Peter Laszlo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [23] Exercise effects on cardiovascular disease: from basic aspects to clinical evidence
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Marin, Jorge
    Perez-Quilis, Carme
    Eijsvogels, Thijs M. H.
    O'Keefe, James H.
    Perez, Marco, V
    Blair, Steven N.
    CARDIOVASCULAR RESEARCH, 2022, 118 (10) : 2253 - 2266
  • [24] Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials
    Matralis, Alexios N.
    Afantitis, Antreas
    Aidinis, Vassilis
    MEDICINAL RESEARCH REVIEWS, 2019, 39 (03) : 976 - 1013
  • [25] Calcium antagonists in cardiovascular disease: Clinical evidence from morbidity and mortality trials
    Oparil, S
    Bakir, SE
    DRUGS, 2000, 59 : 25 - 37
  • [26] Low nephrotoxicity of ibandronate:: Evidence from clinical trials in metastatic bone disease
    Diel, I
    Body, JJ
    Bergström, B
    BONE, 2004, 34 : S77 - S78
  • [27] Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials
    Robins, Sander J.
    Bloomfield, Hanna E.
    CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (04) : 431 - 439
  • [28] Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials
    Drygalski, Krzysztof
    Fereniec, Eliza
    Korycinski, Krzysztof
    Chomentowski, Andrzej
    Kielczewska, Aleksandra
    Odrzygozdz, Cezary
    Modzelewska, Beata
    EXPERIMENTAL GERONTOLOGY, 2018, 113 : 36 - 47
  • [29] Frailty-Guided Management of Cardiovascular Disease-From Clinical Trials to Clinical Practice
    Kim, Dae Hyun
    Zhong, Lily
    Rich, Michael W.
    JAMA CARDIOLOGY, 2023, 8 (10) : 897 - 898
  • [30] Bioactive Compounds for the Management of Hypertriglyceridemia: Evidence From Clinical Trials and Putative Action Targets
    Schiano, Elisabetta
    Annunziata, Giuseppe
    Ciampaglia, Roberto
    Iannuzzo, Fortuna
    Maisto, Maria
    Tenore, Gian Carlo
    Novellino, Ettore
    FRONTIERS IN NUTRITION, 2020, 7
12345